Wirrell, EC
13  results:
Search for persons X
?
6

Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotyp..:

Guerrini, R ; Balestrini, S ; Wirrell, EC.
https://discovery.ucl.ac.uk/id/eprint/10135528/2/Balestrini_Neurology_ms_Rev_Final.pdf.  , 2021
 
?
7

Optimal clinical management of children receiving dietary t..:

Kossoff, EH ; Zupec-Kania, BA ; Auvin, S...
https://pure.eur.nl/en/publications/d3cf0a1a-966c-4f42-a6c9-8020793a6e57.  , 2020
 
?
8

Optimal clinical management of children receiving dietary t..:

Kossoff, EH ; Zupec-Kania, BA ; Auvin, S...
Kossoff , EH , Zupec-Kania , BA , Auvin , S , Ballaban-Gil , KR , Christina Bergqvist , AG , Blackford , R , Buchhalter , JR , Caraballo , RH , Cross , JH , Dahlin , MG , Donner , EJ , Guzel , O , Jehle , RS , Klepper , J , Kang , HC , Lambrechts , DA , Liu , YM , Nathan , JK , Nordli , DR J , Pfeifer , HH , Rho , JM , Scheffer , IE , Sharma , S , Stafstrom , CE , Thiele , EA , Turner , Z , Vaccarezza , MM , van der Louw , E , Veggiotti , P , Wheless , JW & Wirrell , EC 2020 , ' Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group ' , Epilepsia Open , vol. 3 , no. 2 , pp. 175-192 . https://doi.org/10.1002/epi4.12225.  , 2020
 
?
9

Care Delivery for Children With Epilepsy During the COVID-1..:

Wirrell, EC ; Grinspan, ZM ; Knupp, KG...
https://discovery.ucl.ac.uk/id/eprint/10105934/1/0883073820940189.pdf.  , 2020
 
?
11

Optimal clinical management of children receiving dietary t..:

Kossoff, EH ; Zupec-Kania, BA ; Auvin, S...
https://discovery.ucl.ac.uk/id/eprint/10053983/1/Kossoff_et_al-2018-Epilepsia_Open.pdf.  , 2018
 
?
12

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastau..:

Devinsky, O ; Patel, AD ; Cross, JH...
https://discovery.ucl.ac.uk/id/eprint/10050277/3/Cross_nejmoa1714631.pdf.  , 2018
 
?
13

Specific safety and tolerability considerations in the use ..:

Crepeau A ; Moseley BD ; Wirrell EC
http://www.dovepress.com/specific-safety-and-tolerability-considerations-in-the-use-of-anticonv-a10048.  , 2012
 
1-13